Hikal Ltd (HIKA)

Currency in INR
255.75
-0.95(-0.37%)
Closed·
HIKA Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
Unusual trading volume
HIKA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
249.00258.65
52 wk Range
245.00464.75
Key Statistics
Bid/Ask
255.00 / 255.15
Prev. Close
255.75
Open
255.8
Day's Range
249-258.65
52 wk Range
245-464.75
Volume
1.22M
Average Volume (3m)
359.41K
1-Year Change
-21.32%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HIKA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Hikal Ltd Company Profile

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Employees
2061
Market
India

Compare HIKA to Peers and Sector

Metrics to compare
HIKA
Peers
Sector
Relationship
P/E Ratio
49.8x25.9x−0.6x
PEG Ratio
−8.120.060.00
Price/Book
2.5x4.1x2.6x
Price / LTM Sales
1.7x3.3x3.3x
Upside (Analyst Target)
52.5%8.3%38.7%
Fair Value Upside
Unlock15.3%5.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 5.14%
Dividend Yield
0.55%
Industry Median 0.74%
Annualised payout
1.40
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
-1.80 / --
Revenue / Forecast
3.71B / 2.79B
EPS Revisions
Last 90 days

HIKA Income Statement

People Also Watch

717.25
INIR
-0.64%
365.85
BAJE
-1.67%
707.40
BLUJ
-3.96%

FAQ

What Stock Exchange Does Hikal Ltd Trade On?

Hikal Ltd is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Hikal Ltd?

The stock symbol for Hikal Ltd is "HIKA."

What Is the Hikal Ltd Market Cap?

As of today, Hikal Ltd market cap is 31.45B.

What Is Hikal Ltd's Earnings Per Share (TTM)?

The Hikal Ltd EPS (TTM) is 5.14.

When Is the Next Hikal Ltd Earnings Date?

Hikal Ltd will release its next earnings report on 22 Oct 2025.

From a Technical Analysis Perspective, Is HIKA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Hikal Ltd Stock Split?

Hikal Ltd has split 2 times.

How Many Employees Does Hikal Ltd Have?

Hikal Ltd has 2061 employees.

What is the current trading status of Hikal Ltd (HIKA)?

As of 28 Aug 2025, Hikal Ltd (HIKA) is trading at a price of 255.75, with a previous close of 255.75. The stock has fluctuated within a day range of 249.00 to 258.65, while its 52-week range spans from 245.00 to 464.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.